TYPHOID VI POLYSACCHARIDE VACCINE, PRESER

The Defense Logistics Agency awarded Cardinal Health, Inc. a delivery order under the base contract SPE2DX25D8022 for the supply of 20 units of Typhoid Vi Polysaccharide Vaccine, Preserved (NSN 6505015334962), at a total price of $1,981.20, with an award date of July 20, 2026. The contract is designated as a commercial item acquisition under FAR 52.212-4 and incorporates FAR 52.212-5, which governs terms such as inspection, acceptance, and the government’s right to audit, with no alternates selected. The vaccine is to be delivered FOB destination to the USNS LUCY STONE aboard FPO AP 96692-7200, with the contractor responsible for all transportation costs and risks until receipt at the destination. Shipment must occur via the fastest traceable means, excluding parcel post, and all packaging and documentation must be clearly marked with the contract and delivery order numbers, transportation control number, requested delivery date, container count, and applicable NDC code. Acceptance of the product occurs at the delivery point, with the government verifying conformance to contract requirements. Payment will be processed by the Defense Finance and Accounting Service in Columbus, Ohio, to Cardinal Health’s designated billing address in Dublin, Ohio, and electronic invoicing via EDI is required. Cardinal Health, identified by CAGE code 00E55, is classified as other than small and did not claim any socioeconomic status or set-aside designation. The contract includes no options, modifications, or special personnel or security requirements, and while standard DoD logistics practices are followed, no specific MIL-STDs or detailed inspection criteria are referenced beyond general contractual compliance. Administrative oversight is managed by a team including Contracting Officer Lorinda Ferraiolo, Contracting Officer’s Representative Lisa Quinn, and administrative contacts Catherine Gilbert and Michelle Pampel.